Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 5, 2014, Pages 1056-1064

  Jin, Young Joo ^a   Lee, Jin Woo ^a   Lee, Oh Hyun ^a   Chung, Hyun Jung ^a   Kim, Young Soo ^a   Lee, Jung Il ^b   Cho, Soon Gu ^a   Jeon, Yong Sun ^a   Lee, Kun Young ^a   Ahn, Seung Ik ^a   Shin, Woo Young ^a  

^a Inha University Hospital   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Hepatocellular carcinoma; Microvascular invasion; Radiofrequency ablation; Surgery; Transarterial chemoembolization

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR INVASION; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RETREATMENT; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR INVASION; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COMPARATIVE STUDY; HEPATIC ARTERY; LIVER NEOPLASMS; MICROVASCULATURE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; TUMOR RECURRENCE; VASCULARIZATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84898848733     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12507     Document Type: Article

References (28)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001; 2: 533-543.
2. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127: S27-34.
3. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16.
4. Arii S, Yamaoka Y, Futagawa S etal. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32: 1224-1229.
5. Takayama T, Makuuchi M, Hirohashi S etal. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998; 28: 1241-1246.
6. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann. Surg. 1999; 229: 216-222.
7. Okada S, Shimada K, Yamamoto J etal. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994; 106: 1618-1624.
8. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440.
9. Schwartz JD, Schwartz M, Mandeli J, Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol. 2002; 3: 593-603.
10. Lau WY, Leung TW, Ho SK etal. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 1999; 353: 797-801.
11. Takayama T, Sekine T, Makuuchi M etal. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 2000; 356: 802-807.
12. Ikeda K, Arase Y, Saitoh S etal. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000; 32: 228-232.
13. Faber W, Seehofer D, Neuhaus P etal. Repeated liver resection for recurrent hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2011; 26: 1189-1194.
14. Eisele RM, Chopra SS, Lock JF, Glanemann M. Treatment of recurrent hepatocellular carcinoma confined to the liver with repeated resection and radiofrequency ablation: a single center experience. Technol. Health Care 2013; 21: 9-18.
15. Itamoto T, Nakahara H, Amano H etal. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 2007; 141: 589-597.
16. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann. Surg. 2000; 232: 10-24.
17. Lim KC, Chow PK, Allen JC etal. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann. Surg. 2011; 254: 108-113.
18. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 1991; 14: 802-805.
19. Adachi E, Maeda T, Matsumata T etal. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995; 108: 768-775.
20. Choi GH, Kim DH, Kang CM etal. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma. Ann. Surg. Oncol. 2008; 15: 618-629.
21. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
22. Poon RT, Fan ST, Ng IO, Wong J. Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann. Surg. 2000; 231: 544-551.
23. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
24. Jin YJ, Chung YH, Kim JA etal. Predisposing factors of hepatocellular carcinoma recurrence following complete remission in response to transarterial chemoembolization. Dig. Dis. Sci. 2013; 58: 1758-1765.
25. Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000; 31: 899-906.
26. Chan AC, Poon RT, Cheung TT etal. Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. World J. Surg. 2012; 36: 151-156.
27. Sato S, Shiratori Y, Imamura M etal. Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients. J. Hepatol. 2001; 35: 225-234.
28. Bruix J, Sherman M, Llovet JM etal. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 2001; 35: 421-430.